Laura M. Gober, MD, is an attending physician with the Division of Allergy and Immunology at Children's Hospital of Philadelphia.
Areas of Expertise:
Asthma, Atopic dermatitis, Allergic rhinitis, IgE mediated food allergy, Eosinophilic esophagitis, Hives, Food protein induced enterocolitis syndrome, Drug allergy, Mast cell diseases, Other skin disorders, Venom allergy Locations:Specialty Care & Surgery Center, Brandywine Valley
Laura Gober, MD, has long been fascinated by the human immune system. “I think it’s remarkable that microscopic cells do so much to keep us healthy by protecting us from danger in the everyday world around us,” she says.
Dr. Gober was drawn to the field of allergy and immunology by her interest in helping patients with food allergies and eosinophilic esophagitis. “These diseases have a huge impact, not just on the patient, but on the entire family,” she says.
Luckily, great strides are being made in the treatment of these illnesses. “How these conditions develop is still a mystery to us, but so much work is being done to figure out the mystery and to better treat these patients,” Dr. Gober notes.
Interventional approaches such as oral immunotherapy for food allergies — which helps reduce patients’ sensitivity by exposing them to very small quantities of allergens under medical supervision — are exciting to Dr. Gober.
Because severe food allergies can be life-threatening, the steps patients and their families must take to avoid allergens are often extreme. Children who must avoid any exposure to allergens, which are often very common foods, can miss out on many important pursuits as a result.
“Oral immunotherapy, by raising patients’ tolerance of allergens, can have an enormous positive effect, enabling them to engage more fully in everyday life. It can dramatically improve and enrich children’s lives,” Dr. Gober says.
Dr. Gober is also enthusiastic about the promise of biologic medications for conditions such as asthma, hives, and more recently eosinophilic esophagitis. Biologic medications are derived from living organisms such as bacteria, plants or animals, which are modified to target specific molecules in humans.
Biologic medications for eosinophilic esophagitis are a cutting-edge treatment, and Dr. Gober is pleased that she works at CHOP, a center of innovation in pediatric healthcare where patients can take advantage of the very best treatment options.
But it’s also important, Dr. Gober says, that the whole CHOP team “strives to make it a place where children feel comfortable and safe.”
Education and Training
MD - Wright State University School of Medicine, Dayton, OH
University of Maryland Medical Center, Baltimore, MD
The Children's Hospital of Philadelphia, Philadelphia, PA
Johns Hopkins Asthma and Allergy Center, Baltimore, MD
Allergy and Immunology – American Board of Allergy and Immunology
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.